Rhode Island House of Representatives approves bill to legalize psilocybin
The Rhode Island House of Representatives, which is a group of people who make laws, voted and agreed on a new rule. This rule, called bill H5923, is about a substance called psilocybin, which comes from magic mushrooms. The bill says that it should be legal for people to have and grow a small amount of psilocybin for themselves. It also says that adults who are 18 years old or older can share that amount with other adults. Right now, psilocybin is considered illegal and bad, but many people think it could be helpful for some things. So, the bill wants to change the rules to allow it, but the Senate, another group of lawmakers, still needs to think about it and decide if they agree with the new rule.
Nevada governor signs bill to create state’s first psychedelics working group The Governor of Nevada, Joe Lombardo, approved a bill called SB242 that creates a group of people to study psychedelic substances. These substances might help with mental health and end-of-life care. The group will make a plan to make these substances safe and affordable for therapy. The bill doesn't make psychedelics legal yet, but if the group finds them helpful, they could become legal in the future.
GOP Congressman pushes for ibogaine psychedelic therapy Lawmakers and military veterans have introduced a new law called the Douglas 'Mike' Day Psychedelic Therapy to Save Lives Act of 2023. They held a press briefing to talk about it. One congressman and military veteran, Rep. Morgan Luttrell, shared his personal story of how psychedelic therapy changed his life and helped him overcome problems with aggression. The proposed law aims to allocate $75 million for clinical trials studying the effectiveness of psychedelics in treating conditions like PTSD and brain injuries. It would also provide funding for training programs for therapists. If approved, the law would distribute $15 million annually from 2024 to 2028 to various organizations and agencies dedicated to psychedelic research.
New study suggests psychedelic psychotherapy may be useful for treating OCD The researchers found that psilocybin could reduce obsessive behaviors in mice, even without causing hallucinations. They then blocked certain receptors in the mice's brains to remove the psychedelic effects and observed that the reduction in obsessive behaviors still continued. The effects lasted for at least seven days. While these findings are promising, more research is needed to see if the treatment works the same way in humans and if it can provide long-term relief for people with OCD.
|